-
公开(公告)号:US20190181203A1
公开(公告)日:2019-06-13
申请号:US16325550
申请日:2017-08-14
Applicant: Merck Patent GmbH
Inventor: Li Wei TAN , Peter LEVERMORE , Daniel WALKER
Abstract: Electronic device and associated methods with multiple well areas located on a common substrate, where each well area is defined by at least three bank structures that form the side walls of the well area. Within each well area, there are at least two electrode segments where the electrode segments are separated laterally by at least one insulating bank where the insulating bank(s) are thicker than the electrode segments. There is at least one charge transporting layer completely filling the well area in direct contact and overlying both the electrode segments and the insulating bank(s). The well areas are filled using solution methods such as inkjet. Such devices have improved uniformity across the active areas.
-
公开(公告)号:US20200212301A1
公开(公告)日:2020-07-02
申请号:US16631475
申请日:2018-07-25
Applicant: Merck Patent GmbH
Inventor: Elvira MONTENEGRO , Teresa MUJICA-FERNAUD , Florian MAIER-FLAIG , Frank VOGES
IPC: H01L51/00 , C07C211/61 , C07D307/91 , C07D333/76 , C07D209/86 , C07D405/10 , C07D219/02 , C07D265/38
Abstract: The present application relates to a spirobifluorene derivative of a specific formula (I) which is suitable for use in electronic devices.
-
公开(公告)号:US12221572B2
公开(公告)日:2025-02-11
申请号:US17606265
申请日:2020-04-23
Applicant: MERCK PATENT GMBH
Inventor: Elizaveta Kossoy , Shany Neyshtadt , Sanaa Khalil , Alex Rabkin , Jessica Benjamini Ettedgui
Abstract: A semiconducting light emitting nanoparticle is described having a core and shell structure. The particle has a core and an outer layer or shell. The outer layer covers at least part of the core and contains a metal cation and a divalent anion. Additionally, one or more organic moieties are directly attached to the anion of the outer layer by covalent bond. The divalent anion is Se2−, S2−, Te2−, O2− or a combination thereof. The metal cation can be a monovalent, cation, trivalent, or tetravalent cation. Also, a process for synthesizing the semiconducting light emitting nanoparticle is described.
-
公开(公告)号:US12221446B2
公开(公告)日:2025-02-11
申请号:US17258257
申请日:2019-07-02
Applicant: Merck Patent GmbH
Inventor: Rudolf Moser , Viola Groehn , Ruth Boehni Stamm , Fritz Blatter , Martin Szelagiewicz
IPC: C07D475/04 , C07C229/08
Abstract: The present invention is directed to a crystalline salt of 5-methyl-(6S)-tetrahydrofolic acid and L-isoleucine ethyl ester wherein the molar ratio of 5-methyl-(6S)-tetrahydrofolic acid to L-isoleucine ethyl ester is from 1:0.3 to 1:2.0 (in mol/mol) and/or hydrates and/or solvates thereof, as well as, a process of obtaining the same.
-
公开(公告)号:US20250042761A1
公开(公告)日:2025-02-06
申请号:US18920739
申请日:2024-10-18
Applicant: MERCK PATENT GMBH
Inventor: OLIVER DOLL , HAGAI ARBELL , HENNING SEIM
Abstract: A polyoxometalate compound with a polyoxometalate cluster includes Group 5 elements. A formulation is provided that includes the polyoxometalate compound, and a method is provided for preparing an optical metal oxide layer using the formulation and polyoxometalate compound. The obtained optical metal oxide layers are particularly suitable for applications in optical devices such as, for example, in augmented reality (AR) and/or virtual reality (VR) devices.
-
公开(公告)号:USD1060716S1
公开(公告)日:2025-02-04
申请号:US29792342
申请日:2022-03-23
Applicant: Merck Patent GmbH
Designer: Joseph Geringer , Nicolas Couzin
-
公开(公告)号:US20250034306A1
公开(公告)日:2025-01-30
申请号:US18711795
申请日:2022-11-30
Applicant: Merck Patent GmbH
Inventor: Edward W. NG , Durairaj BASKARAN
IPC: C08F220/14 , C08F212/08 , C08F212/12 , C09D125/14 , C09D125/16 , C09D133/06 , C30B19/12 , C30B29/58
Abstract: The invention relates to a random copolymer of structure (A) comprising, a carboxylic acid bearing repeat of structure (I), a 4-vinylbenzocyclobutene derived repeat unit of structure of structure (II), a styrenic repeat unit of structure (III), an alkyl acrylate or alkyl 2-methylenealkanoate derived repeat unit of structure (IV), a hydroxy functionalized alkyl acrylate or alkyl 2-methylenealkanoate derived repeat unit of structure (V), and two end groups as shown in structure (A) one of which is H and the other is a methyl moiety substituted with Rr, Rr1 and Rr2, wherein Rr1, is a C-1 to C-8 alkyl, Rr2 is selected from a C-1 to C-8 alkyl, a C-1 to C-8 alkylene hydroxy moiety (-alkylene-OH), a C-1-C-8 alkylenecarboxylic acid moiety (-alkylenne-CO2H), or a benzylic alcohol comprising moiety of structure (B), Rr is a cyano moiety (—CN) or a carbonylalkyl moiety (—C(═O)—Ri), wherein Ri is a C-1 to C-8 alkyl or an aryl moiety.
-
公开(公告)号:US20250032625A1
公开(公告)日:2025-01-30
申请号:US18705770
申请日:2022-10-31
Applicant: Merck Patent GmbH
Inventor: Timo HEINRICH , Paul Gehrtz
Abstract: Compounds of the formula (I) Q1-Q2-Q3 (I) in which Q1, Q2 and Q3 have the meanings indicated in claim 1, degrade target proteins, and can be employed, inter alia, for the treatment of diseases and conditions mediated by such target proteins.
-
公开(公告)号:US12195488B2
公开(公告)日:2025-01-14
申请号:US16968492
申请日:2019-01-25
Applicant: Merck Patent GmbH
Inventor: Seung Won Ha , Young Hun Byun , Jeum Jong Kim , Ho Hoon Kim , Seong Hak Cheon
Abstract: According to the organometallic compound of the present invention and the thin film manufactured using the same, requirements of high volatility and excellent chemical/thermal stability are satisfied, and significantly improved thin-film deposition rates are exhibited even at low temperatures. In addition, property degradation due to by-products can be improved, excellent step coverage can be realized, and a thin film which, due to having a high dielectric constant, electrically satisfies the equivalent oxide thickness (EOT) requirement while having a thickness at which tunneling does not physically occur can be implemented.
-
公开(公告)号:US12194051B2
公开(公告)日:2025-01-14
申请号:US17288164
申请日:2019-10-22
Applicant: MERCK PATENT GMBH
Inventor: Anne-Laure Blayo , Baptiste Manteau , Camille Amalric , Stanislas Mayer , Stephan Schann , Mickaël Fer
IPC: A61K31/553 , A61K31/4545 , A61K31/46 , A61K31/497 , A61K31/506 , A61K31/5386 , A61P35/00 , C07D471/04 , C07D519/00 , A61K9/00 , A61K9/02 , A61K9/06 , A61K9/08 , A61K9/19 , A61K9/20 , A61K9/28 , A61K45/06 , A61K47/06 , A61P31/00
Abstract: The present invention relates to novel 5-azaindazole derivatives of formula (I), as described and defined herein, and pharmaceutically acceptable salts, solvates and prodrug thereof, as well as pharmaceutical compositions comprising such compounds. The 5-azaindazole derivatives according to the invention have been found to be highly effective dual A2A/A2B adenosine receptor antagonists, and can thus be used as therapeutic agents, particularly in the treatment or prevention of hyperproliferative or infectious diseases or disorders.
-
-
-
-
-
-
-
-
-